C77.4
Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes
C77.4 represents a diagnosis of secondary malignant neoplasm affecting the lymph nodes of the inguinal (groin) region and the lower extremities. This classification signifies that the cancer did not originate within the lymphatic tissue itself but has metastasized from a primary site elsewhere in the body. The inguinal lymph nodes are a common drainage site for malignancies originating in the lower limbs, the perineum, the vulva, the penis, the scrotum, and the anal canal. In some cases, the 'unspecified' designation is used when it is clinically documented that a malignancy is present in these nodes but the documentation does not explicitly clarify if it is primary or secondary, though in the context of the C77 category, it is treated as a secondary spread. Identifying the primary source is critical for determining the appropriate systemic therapy and surgical intervention plan.
Clinical Symptoms
- Palpable, firm, or hard nodules in the groin area
- Painless or painful swelling in the inguinal region
- Unilateral or bilateral lower extremity edema (lymphedema)
- Skin changes over the affected lymph nodes, such as redness or ulceration
- Tenderness in the groin during movement or palpation
- Local discomfort or pressure in the lower limb or pelvic area
- Fever of unknown origin
- Unintentional weight loss
- Night sweats
- General malaise and fatigue
Common Causes
- Metastasis from cutaneous melanoma of the lower extremity or trunk
- Metastasis from squamous cell carcinoma of the skin of the leg, foot, or perineum
- Secondary spread from malignant neoplasms of the vulva
- Secondary spread from malignant neoplasms of the penis or scrotum
- Metastasis from malignant neoplasms of the anal canal
- Spread from gynecological malignancies such as cervical cancer
- Advanced stage of primary pelvic or lower limb cancers
- Lymphatic drainage of circulating tumor cells from the lower half of the body
Documentation & Coding Tips
Specify the laterality of the affected lymph nodes to ensure code specificity.
Example: Patient presents with a firm, 3 cm mass in the right inguinal region. Imaging and subsequent biopsy confirm metastatic squamous cell carcinoma in the right inguinal lymph nodes, secondary to a primary lesion on the right lower extremity. Documentation reflects right-sided involvement for accurate billing and severity tracking.
Billing Focus: Documentation must explicitly state right, left, or bilateral involvement to support specific ICD-10-CM coding and medical necessity for lateralized procedures.
Clearly identify the primary malignancy site when known, as this is required for comprehensive coding.
Example: The patient is diagnosed with secondary malignant neoplasm of the left inguinal lymph nodes. The primary site is documented as a previously excised malignant melanoma of the left heel, Clark Level IV. This link between the secondary and primary site is essential for HCC coding.
Billing Focus: Billing requires both the secondary site code C77.4 and the primary site code to describe the full clinical picture and justify systemic therapy.
Distinguish between superficial and deep inguinal lymph node involvement.
Example: Physical examination reveals matted superficial inguinal lymph nodes on the left. CT imaging further identifies involvement of the deep femoral (Cloquet) nodes. Documentation specifies the depth and extent of nodal involvement to support the complexity of the planned lymphadenectomy.
Billing Focus: Depth of involvement determines the selection of CPT codes for biopsy or excision, ranging from superficial to deep procedures.
Document the presence of associated symptoms such as lymphedema or pain.
Example: Patient with secondary malignancy of bilateral inguinal lymph nodes reports significant Grade 2 lymphedema of the right lower extremity and localized pain. The note includes the management of lymphedema with compression therapy and analgesic requirements.
Billing Focus: Documenting complications like lymphedema supports the use of additional diagnosis codes and justifies specialized physical therapy or supplies.
Detail the clinical morphology and characteristics of the lymph nodes.
Example: On palpation, the inguinal lymph nodes are documented as fixed, non-tender, and matted, measuring 4 cm in the greatest dimension. These characteristics are indicative of metastatic infiltration rather than reactive lymphadenopathy.
Billing Focus: Morphological details provide the clinical evidence necessary to support the diagnosis of a malignant process during an audit.
Note the status of treatment, including current or historical chemotherapy and radiation.
Example: Patient with secondary malignant neoplasm of inguinal lymph nodes is currently undergoing cycle 3 of cisplatin-based chemotherapy. Documentation includes the specific regimen and the patient's tolerance to therapy to justify ongoing encounter codes.
Billing Focus: Treatment status codes (e.g., Z51.11) must be reported alongside C77.4 to capture the nature of the encounter for billing.
Relevant CPT Codes
-
38500 - Biopsy or excision of lymph node(s); open, superficial
Used for diagnostic confirmation of suspected metastasis in easily palpable inguinal nodes.
-
38531 - Biopsy or excision of lymph node(s); open, deep cervical, inguinal, or femoral
Necessary when the metastasis involves deeper nodal chains that require more extensive dissection.
-
38760 - Inguinal lymphadenectomy, superficial, including Cloquet's node
A therapeutic procedure for documented secondary malignancy in the inguinal region.
-
38765 - Inguinal lymphadenectomy, superficial, in continuity with pelvic lymphadenectomy, including external iliac, hypogastric, and obturator nodes
Indicated when inguinal metastasis suggests further spread into the pelvic nodal basins.
-
76700 - Ultrasound, abdominal, real time with image documentation; complete
Used to evaluate for concurrent intra-abdominal metastasis or primary sites like the liver.
-
76856 - Ultrasound, pelvic (nonobstetric), real time with image documentation; complete
Critical for assessing the pelvic primary site and associated iliac nodal involvement.
-
99214 - Office or other outpatient visit for the evaluation and management of an established patient
Standard visit for monitoring patients with metastatic nodal disease requiring treatment adjustments.
-
99215 - Office or other outpatient visit for the evaluation and management of an established patient
Required for complex cases involving metastatic disease progression, new symptoms, and intensive counseling.
-
99204 - Office or other outpatient visit for the evaluation and management of a new patient
Initial consultation for a patient newly diagnosed with metastatic inguinal lymphadenopathy.
-
99205 - Office or other outpatient visit for the evaluation and management of a new patient
Used for new patients presenting with highly complex metastatic disease requiring extensive record review.
Related Diagnoses
- C44.712 - Basal cell carcinoma of skin of left lower limb, including hip
- C43.71 - Malignant melanoma of right lower limb, including hip
- C51.9 - Malignant neoplasm of vulva, unspecified
- C60.9 - Malignant neoplasm of penis, unspecified
- C77.3 - Secondary and unspecified malignant neoplasm of axillary and upper limb lymph nodes
- C79.89 - Secondary malignant neoplasm of other specified sites
- C80.1 - Malignant (primary) neoplasm, unspecified
- I89.0 - Lymphedema, not elsewhere classified
- Z51.11 - Encounter for antineoplastic chemotherapy
- Z85.820 - Personal history of malignant melanoma of skin